Prolonged Bleeding: Drugs That Cause or Treat It
A guide to prolonged bleeding, covering the drugs that trigger it, the medications used to treat it, how it is diagnosed, and when to seek urgent care.
Rapid Heartbeat: What Could Be Causing It?
A board-reviewed clinical guide to the most common and serious causes of rapid heartbeat, how each is diagnosed, and when to seek immediate care. Includes treatment options, drug causes, and a decision framework.
Rebound Weight Gain: Drugs That Cause or Treat It
A guide to rebound weight gain, covering which drugs trigger it, which treat it, why it happens after stopping GLP-1 agonists, and what clinical guidelines recommend for long-term weight maintenance.
Reflux When to See a Doctor: Causes, Diagnosis, and Treatment
Learn when reflux requires medical attention, what causes it, how doctors diagnose it, and which treatments work best. Evidence-based guidance from the HealthRX.com medical team.
Ridged Nails: When to See a Doctor
Vertical and horizontal nail ridges explained: causes, red flags, diagnosis, and treatment. Board-reviewed clinical guidance from the HealthRX.com medical team.
Rumination: Drugs That Cause It, Drugs That Treat It, and What the Evidence Says
Rumination syndrome medication review: baclofen trial results, antidepressant combination therapy, diaphragmatic breathing and how to track regurgitation.
Rumination: When to See a Doctor
Persistent rumination can signal an anxiety disorder, OCD, or depression. Learn the clinical red flags, evidence-based causes, and when to seek professional evaluation.
Skin Sagging After GLP-1 Weight Loss: Causes, Prevention, and Treatment Options
Rapid weight loss from GLP-1 receptor agonists like semaglutide and tirzepatide can cause loose, sagging skin. Learn why it happens, which patients are most at risk, and what medical and cosmetic options actually work.
Skin Tags: Drugs That Cause Them, Treatments That Remove Them, and When to See a Doctor
A guide to the causes, drug associations, diagnosis, and removal options for skin tags, with evidence-based citations throughout.
Slowed Thinking: When to See a Doctor
Slowed thinking can stem from sleep deprivation and stress or signal serious neurological and hormonal conditions. Learn the red-flag symptoms, common causes, diagnostic workup, and evidence-based treatments.
Social Withdrawal: Drugs That Cause It, Drugs That Treat It, and When to Get Help
A guide to social withdrawal covering the medications and medical conditions that trigger it, the evidence-based treatments that reverse it, and the red-flag signs that require urgent evaluation.
Somogyi Effect: Drugs That Cause It, Drugs That Treat It
A clinical guide to the Somogyi effect, what triggers rebound hyperglycemia overnight, which insulin regimens and drugs are responsible, and how to adjust therapy to stop the cycle.
Testicular Pain: Labs, Causes, and Next Steps
A guide to testicular pain covering causes, red flags, recommended labs, imaging, and when to seek emergency care. Includes a practical decision framework for your next steps.
Testicular Pain: Drugs That Cause It, Drugs That Treat It, and When to Act Fast
A guide to every major drug that causes testicular pain and every treatment option available, with dosing details, clinical evidence, and red-flag criteria for emergency care.
Tinnitus: What Could Be Causing It and What to Do Next
A guide to the most common and serious causes of tinnitus, how it is diagnosed, and which treatments have real evidence behind them.
Tinnitus: When to See a Doctor and What Your Symptoms Mean
Learn when tinnitus requires urgent medical attention, what causes the ringing in your ears, how it is diagnosed, and which treatments actually work. Evidence-based guidance from the HealthRX.com medical team.
White Spots on Nails: Drugs That Cause or Treat It
A guide to leukonychia, what causes white spots on nails, which drugs trigger or treat the condition, how it is diagnosed, and when to seek care.
Tadalafil (Generic) Safety for Adults Ages 30 to 49
A guide to tadalafil 2.5 to 20 mg safety for adults aged 30, 49, covering contraindications, drug interactions, cardiovascular risk, side effects, and dosing guidance backed by trial data.
Tadalafil (Generic) Metabolism and Energy Expenditure: A Clinical Deep Dive
How tadalafil 2.5 to 20 mg is absorbed, metabolized via CYP3A4, and cleared, plus the emerging evidence linking PDE5 inhibition to thermogenesis, mitochondrial biogenesis, and metabolic outcomes in humans.
Tadalafil (Generic) Older Adult (50 to 64) Monitoring: Doses, Risks, and Clinical Checkpoints
A guide to monitoring tadalafil 2.5 to 20 mg in adults aged 50, 64, covering cardiovascular safety, drug interactions, BPH/ED overlap, andropause, and lab checkpoints with primary-source citations.
Tadalafil Tmax 2 Hours FDA Label Data
Tadalafil reaches peak plasma at about 2 hours post-dose, with 80% bioavailability and a 17.5-hour half-life per FDA label pharmacokinetic data.
Tadalafil (Generic) Pre-Surgery Hold Window: What Patients and Clinicians Need to Know
Complete clinical guide to the tadalafil pre-surgery hold window: how long to stop tadalafil before any procedure, why the pharmacology demands it, and how to manage BPH/ED patients perioperatively.
Tadalafil (Generic) Muscle Preservation Strategies: A Clinical Guide
A guide to how tadalafil 2.5 to 20 mg supports skeletal muscle preservation, the mechanisms involved, dosing considerations, and how to combine it with exercise and hormone therapy for maximum benefit.
TB-500 Regulatory Status: US, EU, Canada, and UK
A breakdown of TB-500 (thymosin beta-4 active fragment) regulatory status in the United States, European Union, Canada, and United Kingdom, including compounding rules, WADA status, and clinical evidence.
TB-500 Post-Bariatric Surgery Use: What the Evidence Actually Shows
A clinical guide to thymosin beta-4 active fragment (TB-500) after bariatric surgery, covering wound healing, gut-lining repair, absorption changes, dosing considerations, and the current evidence base with primary-literature citations.
Egrifta (Tesamorelin) Geriatric (65+) Monitoring: A Complete Clinical Guide
Evidence-based monitoring protocols for tesamorelin (Egrifta) in adults aged 65 and older with HIV-associated lipodystrophy, covering renal function, glucose metabolism, IGF-1 levels, falls risk, and deprescribing decision points.
Egrifta (Tesamorelin) Post-Bariatric Surgery Use: What Clinicians Need to Know
A clinician-level review of tesamorelin (Egrifta) in post-bariatric patients: mechanism, visceral fat data, GH-axis physiology after surgery, dosing, monitoring, and off-label considerations.
Testosterone Cypionate Appetite & Cravings Changes: What the Evidence Shows
A guide to how testosterone cypionate affects appetite, hunger hormones, food cravings, and caloric intake in men with hypogonadism, with primary-literature citations throughout.
Testosterone Cypionate and Autoimmune Disease: What Clinicians and Patients Need to Know
A clinical deep-dive into how testosterone cypionate affects autoimmune conditions, including immune modulation mechanisms, disease-specific considerations, monitoring protocols, and primary-literature evidence.
Does Blue Cross Blue Shield (Federated) Cover Testosterone Cypionate?
A clinical and insurance guide on Blue Cross Blue Shield (Federated) coverage for testosterone cypionate, including prior authorization criteria, formulary tiers, step therapy requirements, and how to appeal a denial.
Testosterone Cypionate and Cognitive Function: What the Evidence Actually Shows
A deep dive into how testosterone cypionate affects memory, verbal fluency, spatial reasoning, and mood in hypogonadal men, citing T-Trials and primary literature.
Testosterone Cypionate Pharmacogenomics & Genetic Variability: What Your DNA Means for Your TRT Dose
A deep dive into how genetic variants in AR, CYP19A1, SHBG, and CYP3A4/5 alter testosterone cypionate response, dosing, and side-effect risk, with trial citations and clinical decision guidance.
Testosterone Cypionate: Restarting After Acute Illness
A clinician-level guide to safely resuming testosterone cypionate injections after acute illness, covering timing, dose adjustments, lab monitoring, and the evidence behind restart decisions.
Testosterone Cypionate Dosing in Renal Impairment
A clinician-level guide to testosterone cypionate dosing when kidney function is reduced, covering pharmacokinetics, monitoring, dose adjustment strategies, and evidence from primary sources.
Testosterone Cypionate Safety Signals & FDA Actions: A Clinical Reference
A deep dive into testosterone cypionate's known safety signals, FDA label changes, cardiovascular and hematologic risks, and how the drug works at the molecular level.
Testosterone Cypionate Seasonal Use Considerations
A clinical guide to how seasons, light exposure, vitamin D status, and temperature affect testosterone cypionate therapy, with dosing adjustments, monitoring intervals, and primary-literature citations prepared by the HealthRX.com Editorial Team.
Testosterone Cypionate: Switching From / To Other Drugs in Class
A clinician-level guide to switching testosterone cypionate to or from other androgen formulations, covering mechanism, pharmacokinetics, dose conversion, washout periods, and monitoring protocols with PubMed-cited evidence.
Does UnitedHealthcare Cover Testosterone Cypionate?
A detailed guide to UnitedHealthcare coverage for testosterone cypionate, including formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Testosterone Cypionate Bone Health and Density Impact
How testosterone cypionate affects bone mineral density and fracture risk in men with hypogonadism, what the evidence actually shows, and a monitoring framework for prescribers and patients.
Testosterone Cypionate Microdosing Protocols: What the Evidence Actually Shows
A deep dive into testosterone cypionate microdosing protocols, covering pharmacokinetics, dose ranges, injection frequency, clinical trial data, and guideline recommendations for men with hypogonadism.
Testosterone Cypionate Muscle Preservation Strategies: A Clinical Guide
An evidence-based look at testosterone cypionate for muscle preservation in men with hypogonadism, covering dosing tradeoffs, resistance training, nutrition, and monitoring, with explicit notes on what is established versus what still needs verification.
Testosterone Enanthate Pharmacogenomics & Genetic Variability: What Your DNA Means for TRT Response
A deep dive into how genetic variants in AR, CYP19A1, SHBG, and CYP3A4 shape testosterone enanthate pharmacokinetics, efficacy, and side-effect risk, with dosing implications for clinical practice.
Testosterone Suppresses Spermatogenesis: Recovery After Stopping
AUA guideline data on exogenous testosterone and spermatogenesis suppression, with HPG axis recovery timelines from 3 to 24+ months after stopping.
Thymosin Alpha-1 Safety in Adults Ages 30 to 49
A guide to thymosin alpha-1 (thymalfasin) safety for adults aged 30 to 49, covering adverse effects, contraindications, dosing, drug interactions, and what current trial evidence says.
Thymosin Alpha-1 and Pancreatic Cancer Risk: 2025 Review
Thymosin alpha-1 shows no pro-tumorigenic signal in controlled trials to date. Review of mechanism, oncology adjunct data, and surveillance gaps.
Thymosin Alpha-1 Geriatric (65+) Dosing: What Older Adults Need to Know
A guide to thymosin alpha-1 (thymalfasin) dosing in adults aged 65 and older, covering standard regimens, renal adjustments, drug interaction burden, fall risk, and what the trial evidence actually says.
Thymosin Alpha-1 Mechanism of Action: Full Pathway Explained
A physician-oriented explanation of the proposed mechanism of action of thymosin alpha-1 (thymalfasin), covering TLR9 signaling, dendritic cell maturation, T-cell modulation, and NK-cell activation, with an evidence-boundary review of what the clinical trial literature does and does not establish.
Thymosin Alpha-1 Pharmacogenomics & Genetic Variability: What Your DNA Means for Immune Response
A clinician-level review of thymosin alpha-1 (thymalfasin) pharmacogenomics, covering TLR, TLR9, FOXP3, and HLA variants that predict immune response, dosing implications, and the evidence base from hepatitis B/C and oncology trials.
Thymosin Alpha-1 Rebound Effects When Stopping: What the Evidence Actually Shows
Do patients experience immune rebound after stopping thymosin alpha-1 (thymalfasin)? A deep-dive into the clinical evidence, proposed mechanisms, and practical discontinuation guidance.
Thymosin Alpha-1 Cardiovascular Impact: Long-Term Evidence Review
A analysis of thymosin alpha-1 (thymalfasin) cardiovascular effects, covering inflammation pathways, clinical trial data, immune-cardiac crosstalk, and long-term safety signals for clinicians and informed patients.
Thymosin Alpha-1 Pre-Surgery Hold Window: What Clinicians Need to Know
A clinician-level guide to the thymosin alpha-1 (thymalfasin) pre-surgery hold window, covering pharmacology, immune-modulation risk, recommended discontinuation timing, and post-operative restart protocols based on current primary literature.
Levothyroxine and Magnesium Interaction, FDA Guidance
Magnesium cuts levothyroxine absorption by roughly 25 to 40 percent when taken together. Space doses 4 hours apart to avoid the interaction.
Does Selenium Help Hashimoto's Thyroiditis?
Evidence-based review of selenium supplementation for Hashimoto's thyroiditis, plus how to take levothyroxine correctly, how long it takes to work, and whether you can stop it safely.
Hashimoto's Thyroiditis - Symptoms, Labs, and Treatment
Hashimoto's causes 5% of U.S. hypothyroidism cases. Learn the TSH and anti-TPO markers used to diagnose it and how levothyroxine dosing is titrated.
How Long Until Levothyroxine Starts Working?
Levothyroxine begins shifting TSH within days, but most patients need 6 to 8 weeks to feel the full effect. Learn the exact timeline, what affects absorption, and when to call your doctor.
Is a Gluten-Free Diet Useful in Hashimoto's Thyroiditis?
A gluten-free diet may reduce thyroid antibodies in some Hashimoto's patients, especially those with celiac disease or non-celiac gluten sensitivity. Learn what the evidence actually shows, how levothyroxine absorption fits in, and when dietary changes make clinical sense.
Levothyroxine Dosing by Weight: The Complete Clinical Guide
How to calculate levothyroxine dose by weight for hypothyroidism, pregnancy, and post-thyroidectomy patients. Covers weight-based formulas, TSH targets, NDT conversion, T3 protocols, and pregnancy adjustments.
Propylthiouracil (PTU) Uses, Dosing, and Liver Risk
PTU treats hyperthyroidism and thyroid storm, preferred only in first-trimester pregnancy due to methimazole's risks, but carries a black-box liver failure warning.
Selenium Deficiency and Thyroid Health: What the Evidence Shows
Selenium is required for the enzymes that make and convert thyroid hormone. This article separates what is established, what is plausible but unproven, and what remains under study for selenium supplementation in Hashimoto's thyroiditis, Graves' disease, and subclinical hypothyroidism.
Subacute Thyroiditis: Causes, Phases, Diagnosis, and Treatment
A complete clinical guide to subacute thyroiditis covering its four hormonal phases, viral triggers, NSAIDs vs. corticosteroid protocols, and how it differs from Hashimoto's thyroiditis and Graves' disease.